20 to 50     : Prophylactic dose: 1.5 mg daily. See ‘Other Information’
10 to 20     : Reduce dose.
<10           : Reduce dose.
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unlikely to be dialysed. Dose as in GFR <10 mL/min
HD                     :Dialysed. Dose as in GFR <10 mL/min
HDF/high flux   :Dialysed. Dose as in GFR <10 mL/min
CAV/VVHD      :Unknown dialysability. Dose as in GFR 10 to 20 mL/min
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsIncreased risk of bleeding in combination with any other drugs that affect coagulation
ADMINISTRATION
Reconstition
–
Route
SC
Rate of Administration
–
Comments
–
OTHER INFORMATION
In patients with a GFR of 30–50 mL/min and weight >100 kg, give an initial dose of 10 mg then reduce to 7.5 mg daily for treatment of a DVT; use with cautionManufacturer advises to avoid in severe renal impairment due to increased risk of bleedingClearance of fondaparinux increases by up to 20% during haemodialysisHas been used successfully at a dose of 2.5 mg instilled into the dialysis circuit for anticoagulation during dialysis